Assessing statistical applications in publications on Alzheimer's disease

Neuroepidemiology

Volumn 28, Issue 4, 2007, Pages 235-245

  Xiong, Chengjie ^a,b   Tang, Yuxiao ^c   Van Belle, Gerald ^d   Miller, J Philip ^a   Launer, Lenore J ^e   Bergmann, Kelly R ^a   Morris, John C ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Alzheimer's disease; Assessment of Statistical Reporting; Correlational validity; Interrater reliability; Item specific test retest reliability; Survey of Statistical Designs; Survey of Statistical Methods

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; ASSESSMENT OF STATISTICAL REPORTING; CORRELATION COEFFICIENT; INTERMETHOD COMPARISON; MEDLINE; PUBLICATION; RELIABILITY; STATISTICAL ANALYSIS; SURVEY OF STATISTICAL DESIGNS; SURVEY OF STATISTICAL METHODS;

ALZHEIMER DISEASE; DATA INTERPRETATION, STATISTICAL; HUMANS; NEUROPSYCHOLOGICAL TESTS; PUBLICATIONS; QUESTIONNAIRES; RESEARCH DESIGN;

EID: 35348831349     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108598     Document Type: Article

References (68)

1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA: Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119-1122.
2. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, et al: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706.
3. Levy-Lehad E, Wijsman E, Nemens E, et al: A familial Alzheimer's disease locus on chromosome 1. Science 1995;269:970-973.
4. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, et al: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-760.
5. Roses A: Apolipoprotein E, a gene with complex biological interactions in the aging brain. Neurobiol Dis 1997;4:170-186.
6. Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, et al: Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease. Ann Neurol 1996;39:62-70.
7. Selkoe D: Molecular pathology of Alzheimer's disease: the role of amyloid;in Growdon JH, Rossor MN (eds): The Dementias. Boston, Butterworth Heinemann, 1998, pp 257-283.
8. Heston L: Morbid risk in first-degree relatives of persons with Alzheimer's disease. Arch Gen Psychiatry 1988;45:97-98.
9. Brookmeyer R, Gray S, Kawas C: Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998;88:1337-1342.
10. Evans DA, Funkenstein HH, Albert MS, et al: Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 1989;262:2552-2556.
11. Larson EB, Shadlen M-F, et al: Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 2004;6:501-509.
12. Polvikoski T, Sulkava R, Myllykangas L, Notkola I-L, Niinistö L, Verkkoniemi A, Kainulainen K, Kontula K, Pérez-Tur J, Hardy J, Haltia M: Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study. Neurology 2001;56:1690-1696.
13. Stern RG, Mohs RC, Davidson M, Schmeidler J, Silverman J, Kramer-Ginsberg E, Searcey T, Bierer L, Davis KL: A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry 1994;151:390-396.
14. Zonderman AB: Predicting Alzheimer's disease in the Baltimore Longitudinal Study of Aging. J Geriatr Psychiatry Neurol 2005;18:192-195.
15. Riley KP, Snowdon DA, Desrosiers MF, Markesbery WR: Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study. Neurobiol Aging 2005;26:341-347.
16. Davis PB, White H, Price JL, McKeel DW, Robins LN: Retrospective postmortem dementia assessment: validation of a new clinical interview to assist neuropathologic study. Arch Neurol 1991;48:613-617.
17. Hibbard LS, McKeel DW Jr: Automated identification and quantitative morphometry of the senile plaques of Alzheimer's disease. Analyt Quant Cytol Histol 1997;19:123-138.
18. Hibbard LS, McKeel DW Jr, Arnicar-Sulze TL, Burrell LD: Automated detection and morphological analysis of senile plaques in SDAT. J Neurosci Methods 1994;52:175-189.
19. Berg L, McKeel DW Jr, Miller JP, Baty J: Neuropathologic indexes of Alzheimer's disease in demented and nondemented people aged 80 years and older. Arch Neurol 1993;50:349-358.
20. Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders A: Clinicopathological studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 1998;55:326-335.
21. McKeel DW Jr, Ball MJ, Price JL, Smith DS, Miller JP, Berg L, Morris JC: Interlaboratory histopathologic assessment of Alzheimer neuropathology: different methodologies yield comparable diagnostic results. Alzheimer Dis Assoc Disord 1993;7:136-151.
22. Aisen P, Davis K: The search for disease-modifying treatment for Alzheimer's disease. Neurology 1997;48(suppl 6):S35-S41.
23. Rogers S, Farlow M, Doody R, Mohs R, Friedhoff LT: A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 1998;50:136-145.
24. Corey-Bloom J, Anand R, Veach J: A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease. Int J Geriatr Psychopharmacol 1998;1:55-65.
25. Allen H, Burns A: Currrent pharmacological treatments for dementia; in Growdon JH, Rossor MN (eds) The Dementias. Boston, Butterworth Heinemann, 1998, pp 335-357.
26. Consensus report of the Working Group on: molecular and biochemical markers of Alzheimer's disease. Neurobiol Aging 1998;19:109-116.
27. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, et al: Immunization with amyloid β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999;400:173-177.
28. Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ;for the Memantine Study Group: Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 2003;348:1333-1341.
29. Moher D, Jadad AR, Nichol G, et al: Assessing the quality of randomized controlled trials: an annotated bibliography of checklists. Control Clin Trials 1995;16:62-73.
30. Lionel NDW, Herxheimer A: Assessing reports of therapeutical trials. BMJ 1970;3:637-640.
31. Badgley RF: An assessment of research methods reported in 103 scientific articles from two Canadian Medical Journals. Can Med Assoc J 1961;85:246-251.
32. Thomson ME, Kramer MS: Methodological standards for controlled clinical trials of early contact and maternal-infant behaviour. Pediatrics 1984;73:294-300.
33. Mosteller F, Gilbert JP, McPeek B: Reporting standards and research strategies for controlled trials: agenda for the editor. Control Clin Trials 1980;1:37-58.
34. Sacks HS, Berrier J, Reitman D, et al: Metaanalysis of randomized controlled trials. N Engl J Med 1987;316:450-455.
35. DerSimonian R, Charette J, McPeek B, et al: Reporting on methods in clinical trials. N Engl J Med 1982;306:1332-1337.
36. Peto R: Clinical trial reporting. Lancet 1996;348:894-895.
37. Standard of Reporting Trials Group: A proposal for structured reporting of randomized controlled trials. JAMA 1994;272:1926-1931.
38. Bailar JC III, Mosteller F: Guidelines for statistical reporting in articles for medical journals: amplifications and explanations. Ann Intern Med 1988;108:266-273.
39. Hoogstraten N: Reporting treatment results in solid tumours; in Buyse ME, Staquet MJ, Sylvester RJ (eds): Cancer Clinical Trials. Methods and Practice. Oxford, University Press, 1984, pp 139-156.
40. Lang TA, Secic M: How to Report Statistics in Medicine: Annotated Guidelines for Authors, Editors and Reviewers. Philadelphia, The American College of Physicians, 1997.
41. Wilkinson L; Task Force on Statistical Inference of APA Board of Scientific Affairs: Statistical methods in psychology journals: guidelines and explanations. Am Psychol 1999;54:594-604.
42. SAS Institute: SAS Language (Version 8). Cary, SAS Institute, Inc, 1999.
43. Downs SH, Black N: The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomized studies of health care interventions. J Epidemiol Community Health 1998;52:377-384.
44. Spitzer R, Cohen J, Fleiss J, Endicott J: Quantification of agreement in psychiatry diagnosis: a new approach. Arch Gen Psychiatry 1967;17:83-87.
45. Shrout PE, Fleiss JL: Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;2:420-428.
46. Agresti A: Categorical Data Analysis. New York, Wiley, 1990.
47. Avram MJ, Shanks CA, Dykes MHM, Ronai AK, Stiers WM: Statistical methods in anesthesia articles: an evaluation of two American journals during two six-month periods. Anesth Analg 1985;64:607-611.
48. McDermott MM, Lefevre F, Feinglass J, et al: Changes in study design, gender issues, and other characteristics of clinical research published in three major medical journals from 1971 to 1991. J Gen Intern Med 1995;10:13-18.
49. Morris RW: A statistical study of papers in the Journal of Bone and Joint Surgery [BR] 1984. J Bone Joint Surg Br 1988;70:242-246.
50. Pocock SJ, Hughes MD, Lee RJ: Statistical problems in the reporting of clinical trials: a survey of three medical journals. N Engl J Med 1987;317:426-432.
51. Rosenfeld RM, Rockette HE: Biostatistics in otolaryngology journals. Arch Otolaryngol Head Neck Surg 1991;117:1172-1176.
52. Wainapel SF, Kayne HL: Statistical methods in rehabilitation research. Arch Phys Med Rehabil 1985;66:322-324.
53. Schwartz SJ, Sturr M, Goldberg G: Statistical methods in rehabilitation literature: a survey of recent publications. Arch Phys Med Rehabil 1996;77:497-500.
54. Juzych MS, Shin DH, Seyedsadr M, et al: Statistical techniques in ophthalmic journals. Arch Ophthalmol 1992;110:1225-1229.
55. Thornley B, Adams C: Content and quality of 2,000 controlled trials in schizophrenia over 50 years. BMJ 1998;317:1181-1184.
56. Timmer A, Sutherland LR, Hilsden RJ: Development and evaluation of a quality score for abstracts. BMC Med Res Methodol 2003;3:2.
57. Kanter MH, Taylor JR: Accuracy of statistical methods in TRANSFUSION: a review of articles from July/August 1992 through June 1993. Transfusion 1994;34:697-701.
58. Emerson JD, Colditz GA: Use of statistical analysis in the New England Journal of Medicine. N Engl J Med 1983;309:707-713.
59. Colditz GA, Emerson JD: The statistical content of published medical research: some implications for biomedical education. Med Educ 1985;19:248-255.
60. Felson DT, Cupples LA, Meenan RF: Misuse of statistical methods in Arthritis and Rheumatism: 1982 versus 1967-68. Arthritis Rheum 1984;27:1018-1022.
61. Wang Q, Zhang B: Research design and statistical methods in Chinese medical journals. JAMA 1998;280:283-285.
62. Cho MK, Bero LA: Instruments for assessing the quality of drug studies published in the medical literature. JAMA 1994;272:101-104.
63. Feinstein AR, Cicchetti DV: High agreement but low kappa. 1. The problems of two paradoxes. J Clin Epidemiol 1990;43:543-549.
64. Byrt T, Bishop J, Carlin JB: Bias, prevalence, and kappa. J Clin Epidemiol 1993;46:423-429.
65. Dunn HL: Application of statistical methods in physiology. Physiol Rev 1929;9:275-398.
66. Schor S, Karten I: Statistical evaluation of medical journal manuscripts. JAMA 1966;195:1123-1128.
67. Altman DG: Statistics in medical journal. Stat Med 1982;1:59-71.
68. Anderson B: Methodological Errors in Medical Research. Oxford, Blackwell, 1990.